Muriel Hannon

983 total citations
25 papers, 704 citations indexed

About

Muriel Hannon is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Muriel Hannon has authored 25 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 18 papers in Immunology and 5 papers in Oncology. Recurrent topics in Muriel Hannon's work include Hematopoietic Stem Cell Transplantation (19 papers), T-cell and B-cell Immunology (12 papers) and Immune Cell Function and Interaction (12 papers). Muriel Hannon is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), T-cell and B-cell Immunology (12 papers) and Immune Cell Function and Interaction (12 papers). Muriel Hannon collaborates with scholars based in Belgium, Switzerland and United States. Muriel Hannon's co-authors include Frédéric Baron, Yves Béguin, Stéphanie Humblet‐Baron, Joan Somja, Grégory Ehx, Loïc Delens, Ludovic Belle, Chantal Lechanteur, Alexandra Briquet and Sophie Servais and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Journal of Hepatology.

In The Last Decade

Muriel Hannon

24 papers receiving 698 citations

Peers

Muriel Hannon
Hande H. Tuncer United States
Tom Erkers Sweden
Michael Lioznov Germany
Ryan Flynn United States
Simon Le Gallou France
H.-D. Kleine Germany
Stuart J. Ings United Kingdom
L. Benninger United States
Philippe Hénon France
Darin Sumstad United States
Hande H. Tuncer United States
Muriel Hannon
Citations per year, relative to Muriel Hannon Muriel Hannon (= 1×) peers Hande H. Tuncer

Countries citing papers authored by Muriel Hannon

Since Specialization
Citations

This map shows the geographic impact of Muriel Hannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Hannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Hannon more than expected).

Fields of papers citing papers by Muriel Hannon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muriel Hannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Hannon. The network helps show where Muriel Hannon may publish in the future.

Co-authorship network of co-authors of Muriel Hannon

This figure shows the co-authorship network connecting the top 25 collaborators of Muriel Hannon. A scholar is included among the top collaborators of Muriel Hannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muriel Hannon. Muriel Hannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ehx, Grégory, Muriel Hannon, Sophie Dubois, et al.. (2021). Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis. American Journal of Transplantation. 21(8). 2662–2674. 15 indexed citations
2.
Grégoire, Céline, Muriel Hannon, Laurence Seidel, et al.. (2019). Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model. Frontiers in Immunology. 10. 619–619. 61 indexed citations
3.
Ehx, Grégory, Joan Somja, Hans-Jörg Warnatz, et al.. (2018). Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice. Frontiers in Immunology. 9. 1943–1943. 63 indexed citations
4.
Delens, Loïc, Grégory Ehx, Joan Somja, et al.. (2018). In Vitro Th17-Polarized Human CD4+ T Cells Exacerbate Xenogeneic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 25(2). 204–215. 21 indexed citations
5.
Servais, Sophie, Muriel Hannon, Régis Peffault de Latour, Gèrard Socié, & Yves Béguin. (2017). Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications. PubMed. 4(6). 40–40. 15 indexed citations
6.
Detry, Olivier, Marie‐Hélène Delbouille, Joan Somja, et al.. (2017). Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I–II, open-label, clinical study. Journal of Hepatology. 67(1). 47–55. 104 indexed citations
7.
Ehx, Grégory, Joan Somja, Loïc Delens, et al.. (2017). Comparison of xenogeneic graft-versus-host reactions in humanized NSG and NSG-HLA-A2/HHD mice. Open Repository and Bibliography (University of Liège). 1 indexed citations
8.
Belle, Ludovic, Joan Somja, Philippe Delvenne, et al.. (2016). Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease. PLoS ONE. 11(12). e0167997–e0167997. 3 indexed citations
9.
Servais, Sophie, Yves Béguin, Loïc Delens, et al.. (2016). Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Investigational Drugs. 25(8). 957–972. 24 indexed citations
10.
Ehx, Grégory, Joan Somja, Loïc Delens, et al.. (2016). Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease. Journal of Hematology & Oncology. 9(1). 53–53. 22 indexed citations
11.
Hannon, Muriel, Yves Béguin, Grégory Ehx, et al.. (2015). Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Following Flu-TBI versus TLI-ATG Conditioning. Clinical Cancer Research. 21(14). 3131–3139. 24 indexed citations
12.
Hannon, Muriel, Stéphanie Humblet‐Baron, Étienne Baudoux, et al.. (2015). Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation. Cancer Immunology Immunotherapy. 64(8). 989–998. 4 indexed citations
13.
Ehx, Grégory, Muriel Hannon, Yves Béguin, Stéphanie Humblet‐Baron, & Frédéric Baron. (2015). Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets. Oncotarget. 6(41). 43255–43266. 14 indexed citations
14.
Béguin, Yves, Ludovic Belle, Muriel Hannon, et al.. (2014). Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation. PLoS ONE. 9(11). e113764–e113764. 10 indexed citations
15.
Baron, Frédéric, Stéphanie Humblet‐Baron, Grégory Ehx, et al.. (2014). Thinking Out of the Box—New Approaches to Controlling GVHD. Current Hematologic Malignancy Reports. 9(1). 73–84. 6 indexed citations
16.
Fillet, Marianne, Muriel Hannon, Laurence Seidel, et al.. (2013). Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning. PLoS ONE. 8(2). e55876–e55876. 10 indexed citations
17.
Bruck, France, Ludovic Belle, Chantal Lechanteur, et al.. (2013). Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Cytotherapy. 15(3). 267–279. 42 indexed citations
18.
Hannon, Muriel, Chantal Lechanteur, Sophie Lucas, et al.. (2013). Infusion of clinical‐grade enriched regulatory T cells delays experimental xenogeneic graft‐versus‐host disease. Transfusion. 54(2). 353–363. 50 indexed citations
19.
Hannon, Muriel, Stéphanie Humblet‐Baron, Carlos Graux, et al.. (2012). Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning. Haematologica. 97. 1 indexed citations
20.
Castermans, Emilie, Muriel Hannon, Pierre Drion, et al.. (2009). Reconstitution du système immunitaire après allogreffe de cellules souches hématopoïétiques.. RMLG. Revue médicale de Liège. 64. 2–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hande H. Tuncer Breakdown of academic impact, for papers by Tom Erkers Breakdown of academic impact, for papers by Michael Lioznov Breakdown of academic impact, for papers by Ryan Flynn Breakdown of academic impact, for papers by Simon Le Gallou Breakdown of academic impact, for papers by H.-D. Kleine Breakdown of academic impact, for papers by Stuart J. Ings Breakdown of academic impact, for papers by L. Benninger Breakdown of academic impact, for papers by Philippe Hénon Breakdown of academic impact, for papers by Darin Sumstad
Rankless by CCL
2026